期刊文献+

LC-MS/MS法测定人血浆中8'-羟基二氢麦角隐亭浓度及其在生物等效性研究中的应用

Determination of 8′-hydroxy-dihydroergocryptine in human plasma by LC-MS/MS and its application to a bioequivalence evaluation
在线阅读 下载PDF
导出
摘要 建立一种快速测定人血浆中8'-羟基二氢麦角隐亭(8'-OH-DHEC)浓度的LC-MS/MS法,以曲马多为内标,采用C18反相柱(150 mm×2.0 mm,5μm),柱温35℃。流动相为甲醇-水(含0.1%甲酸),流速0.2 mL/min;电喷雾离子化(ESI),正离子扫描,选择性反应监测(SRM)8'-OH-DHEC m/z 594.3→270.0;曲马多m/z 264.1→58.3。本方法专属性强,8'-OH-DHEC在50~4 000 pg/mL呈良好的线性关系,r=0.999 3,最低检测浓度为50 pg/mL,低、中、高浓度下的日内及日间精密度、准确度、稳定性等均符合生物样品测定要求。本方法应用于22名健康受试者口服4 mg麦角隐亭的生物等效性研究,结果表明此方法专属性强,快速灵敏,适用于临床剂量下麦角隐亭药代动力学及生物等效性研究。 A sensitive,selective and simple liquid chromatography tandem mass spectrometry(LC-MS/MS) method was developed for determining the major active metabolite 8′-hydroxy-dihydroergocryptine(8′-OH-DHEC) of α-dihydroergocryptine(DHEC) in human plasma.The analyte was extracted from plasma samples by liquid-liquid extraction,separated through a Shimadzu shim-pack VP-ODS column(150 mm×2.0 mm,5 μm) using isocratic mobile phase consisting of 0.1% formic acid-methanol(48 ∶52),and analyzed by electro-spray ionization(ESI) in the selected reaction monitoring mode.The precursor to product ion transitions of m/z 594.3→270.0 and m/z 264.1→58.3 were used to measure 8′-OH-DHEC and the IS tramadol,respectively.The method was validated over a concentration range of 50-4 000 pg/mL.The intra-and inter-day precision values were less than 10% and accuracy values 90%-110%.The stability of 8′-OH-DHEC in human plasma under different storage conditions met the requirements of bioanalytical method.The established method was successfully applied to a bioequivalence study after single oral administration of 4 mg DHEC mesilate(test and reference) in 22 healthy volunteers.The 90% confidence intervals of log‐transformed ratios of the cmax and AUC0-t were 89.68%-129.9%,106.9%-121.8%,respectively.The method is selective and suitable for the quantification of 8′-OH-DHEC in human plasma.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2012年第2期177-181,共5页 Journal of China Pharmaceutical University
关键词 α-二氢麦角隐亭 8'-羟基二氢麦角隐亭 LC-MS/MS 代谢物 生物等效性 α-dihydroergocryptine 8′-hydroxy-dihydroergocryptine LC-MS/MS metabolite bioequivalence
作者简介 通讯作者Tel:025—83271260E—mail:lxq—cpu@yahoo.com.cn
  • 相关文献

参考文献10

  • 1Bernocchi G,Gerzeli G,Scherini E,et al.Neuroprotective effectsof alpha-dihydroergocryptine against damages in the substantianigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine[J].Acta Neuropathol,1993,85(4):404-413.
  • 2Althaus M,Retzow A,Castell JV,et al.In vitro identification ofthe cytochrome P450 isoform responsible for the metabolism ofalpha-dihydroergocryptine[J].Xenobiotica,2000,30(11):1 033-1 045.
  • 3Aellig WH.Investigation of the venoconstrictor effect of 8'hydroxydihydroergotamine,the main metabolite of dihydroergota-mine,in man[J].Eur J Clin Pharmacol,1984,26(2):239-242.
  • 4Bicalho B,Giolo JM,Lilla S,et al.Identification and human phar-macokinetics of dihydroergotoxine metabolites in man:preliminaryresults[J].Biopharm Drug Dispos,2008,29(1):17-28.
  • 5Maurer G,Frick W.Elucidation of the structure and receptorbinding studies of the major primary,metabolite of dihydroergota-mine in man[J].Eur J Clin Pharmacol,1984,26(4):463-470.
  • 6Althaus M,de Mey C,Ezan E,et al.Plasma and urine pharmaco-kinetics of the dopamine agonist alpha-dihydroergocryptine inpatients with hepatic dysfunction[J].Int J Clin Pharmacol Ther,2001,39(2):67-74.
  • 7de Mey C,Sulowicz W,Stompor T,et al.Single dose pharmacoki-netics of alpha-dihydroergocryptine in patients with moderate tosevere renal insufficiency[J].Arzneimittelforschung,2003,53(11):769-773.
  • 8Ezan E,Ardouin T,Delhotal Landes B,et al.Bioequivalencestudy of alpha-dihydroergocryptine:utility of metabolite evaluation[J].Int J Clin Pharmacol Ther,1996,34(1):32-37.
  • 9Friedrich G,Appel K,Rose T,et al.Determination of dihydroer-gocryptine in human plasma and urine samples using on-linesample extraction-column-switching reversed-phase liquidchromatography-mass spectrometry[J].J Chromatogr B AnalytTechnol Biomed Life Sci,2004,808(2):131-139.
  • 10Cvak L,Stuchlik J,Schreiberova M,et al.Selective reduction ofpeptidic ergot alkaloids[J].Collect Czech Chem Commun,2000,65:1 762-1 776.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部